Showing results (1721-1730 of 5,607) with videos related to

Sort By:
Pageof 561
Nuclear Medicine Communications|May 15, 2020
Detectability of small objects in PET/computed tomography phantom images with Bayesian penalised likelihood reconstructionMargo-Rose F Macnab, Thomas J Biggans, Fergus I Mckiddie, et al.
Nuclear Medicine Communications|August 30, 2021
18F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic reviewFrancesco Dondi, Domenico Albano, Raffaele Giubbini, et al.
Nuclear Medicine Communications|August 30, 2021
The value of preoperative 18F-FDG PET metabolic and volumetric parameters in predicting microvascular invasion and postoperative recurrence of hepatocellular carcinomaChunjuan Jiang, Guang Ma, Qiufang Liu, et al.
Nuclear Medicine Communications|August 30, 2021
Optimization of cross-calibration factor for quantitative bone SPECT without attenuation and scatter correction in the lumbar spine: head-to-head comparison with attenuation and scatter correctionHajime Ichikawa, Masahisa Onoguchi, Takayuki Shibutani, et al.
Nuclear Medicine Communications|August 18, 2021
Quantitative analysis in parathyroid adenoma scintigraphyMartin Havel, Vladimir Dedek, Michal Kolacek, et al.
Nuclear Medicine Communications|August 18, 2021
Analysis of absorbed dose in radioimmunotherapy with 177Lu-trastuzumab using two different imaging scenarios: a pilot studyAmit Nautiyal, Ashish K Jha, Sneha Mithun, et al.
Nuclear Medicine Communications|May 7, 2020
Logistic regression analysis of repeated radioiodine therapy treatments for papillary thyroid carcinoma patientsKhaled Soliman, Hasna Albander, Ahmed Alenezi
Nuclear Medicine Communications|May 7, 2020
Physiological fluorodeoxyglucose uptake of spinal cord in adultsLevent A Guner, Kemal Unal, Erkan Vardareli, et al.
Nuclear Medicine Communications|May 7, 2020
Timing of peptide receptor radiotargeted therapy in relation to cardiac valve surgery for carcinoid heart disease in patients with neuroendocrine metastases and cardiac syndrome. A single-centre study from a centre of excellenceLaura May Davis, N Nicou, Wendy Martin, et al.
Nuclear Medicine Communications|September 1, 1989
Radioimmunoscintigraphy with 111In labelled monoclonal antibody fragments (F(ab')2 BW 431/31) against CEA: radiolabelling, antibody kinetics and distribution, findings in tumour and non-tumour patientsR Bares, J Fass, S Truong, et al.
Pageof 561